← Back to Search

Screening Methods for Swallowing Disorders

N/A
Waitlist Available
Led By Oliver Acosta, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 minutes
Awards & highlights

Study Summary

This trial compares two tests to spot dysphagia and aspiration risks after a stroke.

Who is the study for?
This trial is for adults aged 18-80 who've had an ischemic stroke within the last month and are at Lynn Rehabilitation Center. They must understand English or Spanish, be able to consent (or have a proxy do so), and not have a history of swallowing issues or certain brain injuries.Check my eligibility
What is being tested?
The study compares two tests for dysphagia after an ischemic stroke: one is a non-standardized clinical evaluation, and the other uses the Mann Assessment of Swallowing Ability. It aims to identify which better detects swallowing difficulties and aspiration risk.See study design
What are the potential side effects?
Since this trial involves screening tools rather than medications, there are no direct side effects from interventions. However, discomfort during swallow evaluations may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Deglutition Disorders

Trial Design

2Treatment groups
Experimental Treatment
Group I: Non-standardized clinical swallow evaluation GroupExperimental Treatment1 Intervention
Participants in this group will receive standard of care treatment (dysphagia screening once upon admission to inpatient rehabilitation using a non-standardized clinical swallow evaluation for approximately 15 minutes).
Group II: Mann Assessment of Swallowing Ability (MASA) GroupExperimental Treatment1 Intervention
Participants in this group will receive the MASA dysphagia screening once upon admission to inpatient rehabilitation for approximately 20 minutes.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
898 Previous Clinical Trials
409,601 Total Patients Enrolled
Oliver Acosta, MDPrincipal InvestigatorUniversity of Miami
Gemayaret Alvarez, MDPrincipal InvestigatorUniversity of Miami

Media Library

Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool) Clinical Trial Eligibility Overview. Trial Name: NCT05603897 — N/A
Swallowing Difficulty Research Study Groups: Mann Assessment of Swallowing Ability (MASA) Group, Non-standardized clinical swallow evaluation Group
Swallowing Difficulty Clinical Trial 2023: Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool) Highlights & Side Effects. Trial Name: NCT05603897 — N/A
Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05603897 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for this experiment at the moment?

"This clinical trial, initially published on January 4th 2023 and last modified on October 28th 2022 is no longer recruiting patients. While this study has ended, there are 74 other trials actively searching for participants at the moment."

Answered by AI
~33 spots leftby Jan 2025